Mark Newman, Author at Endocrine News

Liver Disease

Guilt by Association: The Link Between NASH, MAFLD, Diabetes, and Obesity

As obesity rates continue to climb so does metabolic associated fatty liver disease (MAFLD), often at an alarming rate. Endocrine News talks to Theodore C. Friedman, MD, PhD, and Magda Shaheen, MD, PhD, about research they presented at ENDO 2023 on fatty liver disease’s link to diabetes, what impact new medications could have, and how...

Liver Disease

Endocrine Targets: Treating Steatotic Liver Disease

Endocrine dysfunction plays a prominent role in the development of steatotic liver disease and was featured prominently with a multi-session program at ENDO 2023. Endocrinologists will be on the front lines to help patients stave off this disorder that will no longer be known as “fatty liver disease,” which is projected to become the leading...

Obesity

Endocrine Society Works to Advance Obesity Legislation in Congress

The Endocrine Society continues to be a vocal advocate to advance legislation that would address prevention and treatment of obesity. In late July, legislation known as the Treat and Reduce Obesity Act (TROA) that the Society endorsed was introduced in the House and the Senate. This important bipartisan legislation would take steps to ensure that...

Endocrine Disruptors

European Parliament Dances Around EDC Legislation

The Endocrine Society has worked in the European Union (EU) to advance legislation to regulate endocrine-disrupting chemicals (EDCs) consistent with the ambitions of the EU Green Deal. As the European Parliament returns in September following the summer recess, legislation is moving forward in certain areas, but a comprehensive approach remains just beyond the horizon for...

Reproductive Issues

Women with PCOS on Keto Diet May See Improvements in Fertility

The ketogenic (keto) diet may lower testosterone levels in women with polycystic ovary syndrome (PCOS), according to a new paper published in the Journal of the Endocrine Society. PCOS is the most common hormone disorder in women, affecting 7% – 10% of women of childbearing age. It can cause infertility and raises the risk of developing...

Research

Endocrine Society Rallies for Medical Research as Congressional Deadline to Fund Government Approaches

The Federal Government is funded through an annual appropriations process in which both the House of Representatives and the Senate develop funding bills to support 12 different areas of the government, iron out differences, and pass bills by a September 30 deadline or risk shutting down the federal government. The funding bill that covers most...

Non-Alcoholic Fatty Liver Disease: The Silent Epidemic and Emerging Research for Detection and Treatment

Along with the public health challenges of obesity and diabetes, endocrinologists are now becoming keenly aware of the prevalence of another ominous threat: non-alcoholic steatohepatitis (NASH). Endocrine Society members Abhinav Seth, MD, PhD, and Roberto Calle, MD, both with Regeneron, give Endocrine News an exclusive primer on this disorder, as well as a future path...

ENDO 2023

ENDO 2023: Reunited and It Felt So Good!

While last year was the first time we devoted an entire issue of Endocrine News to ENDO, we’re doing it again this year since ENDO 2023 was the first completely in-person conference since 2019 in New Orleans! Since thousands of endocrinologists descended on Chicago from around the world to see firsthand the amazing amount of...